All trials - page: 186

All trials

Displaying of results
Download as CSV
NCTID
Brief title
Sponsor
Design
Criteria
Status
Target enrollment
Study phase & design
Primary intervention type
Primary potential benefit
Outcome measure
Follow up
Start date
First posted
Location
NCT05152290Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for SCIThe Foundation for Orthopaedics and Regenerative Medicine
  • Age All ages
  • Level -
  • AIS A, B, C, D, E
  • All
Recruiting20PHASE1Biological/cell basedGeneral health06 July 202209 December 20215
NCT05144113FES-Rowing: Preventing the Secondary Conditions of Paralysis Through Vigorous ExerciseSpaulding Rehabilitation Hospital
  • Age ≥ 18 yrs
  • Level -
  • AIS A, B, C, D, E
  • All
Ended2021 March 202103 December 20211
NCT05142111Pilot Study on EEG and Behavioral Effects of Two Different Treatments on Sexual LifeIRCCS San Camillo, Venezia, Italy
  • Age ≥ 18 yrs
  • Level -
  • AIS A, B, C, D
  • All
60NAPsychosocial/otherSexual health01 April 202102 December 20211
NCT05139732Exploring Functional Paralysis With Advanced Magnetic Resonance ModalitiesSwiss Paraplegic Research, Nottwil
  • Age 18 - 65 yrs
  • Level -
  • AIS A, B, C, D, E
  • All
Ended6904 November 202201 December 20212
NCT05181150Gut Peptides and Bone Remodeling in Individuals With Spinal Cord InjuryUniversity of Copenhagen
  • Age 18 - 80 yrs
  • Level -
  • AIS
  • All
  • primarily use a wheelchair
20NAPsychosocial/otherBone health240 minutes16 November 202106 January 20221
NCT05180032Treatment With Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCIJames J. Peters Veterans Affairs Medical CenterParallel Assignment
  • Age 18 - 50 yrs
  • Level C4-S5
  • AIS A, B, C
  • 3 years - 15 years
  • be wheelchair dependent greater than 75% of the time
Recruiting39Phase 4DrugBone health24 months01 March 202106 January 20222